Promised regulatory crackdowns in Germany and Australia have stalled, but patients are already paying the price — and European exporters are watching closely.

Disposable vapes, infused pre-rolls, and oral pouches are redefining what cannabis consumers actually want to buy.

The science of drying and curing is often overlooked, but it may be the most consequential stage in medical cannabis production.

A bitter public dispute between two of the industry's largest operators exposes the fragile economics driving consolidation in global cannabis markets.

New market analysis projects robust expansion across medical and adult-use segments, with regulatory fragmentation the key variable to watch.

Britain's prescription market is expanding at a pace that has surprised even industry insiders, raising pointed questions for EU regulators.

The UNODC's World Drug Report 2026 finds 256 million cannabis users globally — but reform and the black market are evolving in tandem.

A rare cannabinoid is attracting serious research attention — but the evidence remains preliminary and the clinical questions are far from settled.